Press release
Asia Pacific Digital Therapeutics Market Trends, Industry Outlook | Key Companies - Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG
Asia Pacific Digital Therapeutics Market
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/asia-pacific-digital-therapeutics-market?sp
Asia Pacific: Recent Industry Developments
✅ In September 2025, CureApp launched a digital therapeutics platform in Japan for managing chronic respiratory diseases. The system integrates AI-guided therapy with patient mobile apps. Early adoption shows improved treatment adherence and patient engagement.
✅ In August 2025, Omron Healthcare introduced AI-powered digital therapeutics for hypertension management in Japan and South Korea. The platform provides personalized lifestyle recommendations based on real-time data. Initial deployments highlight improved blood pressure control and patient compliance.
✅ In July 2025, ResApp Health expanded its digital therapeutics solutions for respiratory and sleep disorders across Australia. The platform combines mobile monitoring with AI analytics to guide interventions. Pilot programs report enhanced clinical outcomes and reduced hospital visits.
✅ In June 2025, HealthTech startups in Singapore launched digital therapeutics apps targeting mental health and stress management. The platforms use AI-based cognitive behavioral therapy modules. Early adoption shows higher engagement rates and measurable improvements in patient well-being.
Asia Pacific Digital Therapeutics Market: Drivers
The Asia Pacific digital therapeutics (DTx) market is witnessing strong growth as healthcare providers, payers, and patients increasingly adopt software-driven interventions for the prevention, management, and treatment of chronic and lifestyle-related diseases. Digital therapeutics utilize evidence-based digital platforms, mobile applications, and remote monitoring systems to deliver personalized treatment plans, behavioral therapy, and real-time feedback. Rising prevalence of conditions such as diabetes, cardiovascular disorders, mental health issues, and obesity is driving demand for scalable, accessible, and patient-centric digital healthcare solutions. Continuous advancements in AI, machine learning, and wearable technology are enhancing the precision, engagement, and efficacy of digital therapeutics. Growing government initiatives, insurance reimbursements, and investment in digital health infrastructure are further supporting market expansion.
Countries such as China, Japan, South Korea, and India are leading the Asia Pacific digital therapeutics market, driven by strong technological infrastructure, increasing smartphone penetration, and growing awareness of digital health solutions. China is expected to witness significant growth due to supportive government policies, a large patient population, and rapid adoption of telemedicine and mobile health apps. Japan's focus on aging population health management and precision medicine is fostering adoption, while India and South Korea are seeing increased use of mobile-based DTx solutions for chronic disease management and mental health care. Integration with electronic health records, wearable devices, and telehealth platforms is enhancing patient monitoring, adherence, and clinical outcomes. With technological advancements, rising healthcare demand, and supportive regulatory environments, the Asia Pacific digital therapeutics market is poised for continued robust growth.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/asia-pacific-digital-therapeutics-market?sp
Asia Pacific Digital Therapeutics Market: Major Players
Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH
Segment Covered in the Asia Pacific Digital Therapeutics Market:
➥ By Product Type: Software, Devices, Others
➥ By Application: Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others
➥ By Sales Channel: Business-to-Business (B2B), Business-to-Consumer (B2C)
Research Process:
Both primary and secondary data sources have been used in the Asia Pacific Digital Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Most Frequently Asked Questions in the Asia Pacific Digital Therapeutics Market Research Industry:
➠ Who leads the Asia Pacific Digital Therapeutics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Asia Pacific Digital Therapeutics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Asia Pacific Digital Therapeutics market growth?
➠ What are the dominant sales and distribution strategies in the Asia Pacific Digital Therapeutics industry?
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=asia-pacific-digital-therapeutics-market
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific Digital Therapeutics Market Trends, Industry Outlook | Key Companies - Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG here
News-ID: 4198924 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States PCSK9 Inhibitor Market 2025 | Growth Drivers, Competitive Landscap …
Market Size and Growth
PCSK9 Inhibitor Market reached US$ 1.96 Billion in 2024 and is expected to reach US$ 7.67 Billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Merck's investigational oral PCSK9 inhibitor, Enlicitide Decanoate, achieved all primary and key secondary endpoints in the pivotal CORALreef Lipids study, demonstrating significant LDL-C reduction compared to placebo.
✅ In March…
Latin America Digital Pathology Market Outlook by 2030 | Leading Players - Perki …
"Latin America Digital Pathology Market is expected to grow at a CAGR of 10.09% during the forecast period 2023-2030." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/latin-america-digital-pathology-market?sp
Latin America: Recent Industry Developments
✅ In September 2025, Roche Diagnostics launched AI-enabled digital pathology platforms in Brazil for cancer diagnostics. The system integrates whole-slide imaging with machine learning analysis. Early adoption shows faster diagnosis and…
Asia Pacific Protein Chip Market Trends, Latest innovations | Leading Players - …
"The Asia Pacific Protein Chip Market is expected to grow at a CAGR of 18.6% during the forecast period 2023-2030." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/asia-pacific-protein-chip-market?sp
Asia Pacific: Recent Industry Developments
✅ In September 2025, CureApp launched a digital therapeutics platform in Japan for managing chronic respiratory diseases. The system integrates AI-guided therapy with patient mobile apps. Early adoption shows improved…
United States Cell Regeneration Medicine Market 2025| Growth Drivers, Competitiv …
Market Size and Growth
The global cell regeneration medicine market reached US$ 34.3 billion in 2023 and is expected to reach US$ 90.1 billion by 2031, growing at a CAGR of 12.8% during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Bayer advanced its Parkinson's disease cell therapy into Phase III trials. Developed by subsidiary BlueRock, the therapy aims to replace lost dopamine-producing neurons using stem cells.…
More Releases for Asia
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,…
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022.
23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property…
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019".
The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn…
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia
Equipping Asia’s navies with the latest diving technology for asymmetric warfare and
operations
SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is
seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting…
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients.
Asked to comment on the move, Luke Palmer, the…
